Regulation of magnesium balance: Lessons learned from human genetic disease

CKJ: Clinical Kidney Journal

Volumn 5, Issue SUPPL. 1, 2012, Pages

  De Baaij, Jeroen H F ^a   Hoenderop, Joost G J ^a   Bindels, René J M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

human genetic disease; hypomagnesaemia; magnesium homeostasis; TRPM6

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CLAUDIN 16; CLAUDIN 2; EPIDERMAL GROWTH FACTOR; HEPATOCYTE NUCLEAR FACTOR 1; HOMEODOMAIN PROTEIN; MAGNESIUM; MUTANT PROTEIN; POTASSIUM CHANNEL KV1.1; SODIUM CHLORIDE COTRANSPORTER; TRANSIENT RECEPTOR POTENTIAL CHANNEL M6; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7;

AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; BARTTER SYNDROME; BONE TISSUE; CALCIUM TRANSPORT; CHRONIC KIDNEY FAILURE; DOWNSTREAM PROCESSING; ESTROGEN THERAPY; GENE IDENTIFICATION; GENE MUTATION; GENETIC DISORDER; GITELMAN SYNDROME; HENLE LOOP; HEREDITARY HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA; HOMEOSTASIS; HUMAN; HYPERCALCIURIA; HYPOCALCEMIA; HYPOMAGNESEMIA; INTESTINE ABSORPTION; INTRACELLULAR TRANSPORT; KIDNEY CALCIFICATION; KIDNEY DISTAL TUBULE; KIDNEY TUBULE ABSORPTION; KNOCKOUT MOUSE; MAGNESIUM BLOOD LEVEL; MAGNESIUM METABOLISM; MAGNESIUM URINE LEVEL; MATURITY ONSET DIABETES MELLITUS; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTAKE; QUANTITATIVE TRAIT LOCUS MAPPING; REVIEW; TIGHT JUNCTION; TRANSCYTOSIS; URINARY EXCRETION;

EID: 84864449052     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ndtplus/sfr164     Document Type: Review

References (79)

1. Musso CG. Magnesium metabolism in health and disease. Int Urol Nephrol 2009; 41: 357-362
2. Quamme GA. Recent developments in intestinal magnesium absorption. Curr Opin Gastroenterol 2008; 24: 230-235
3. Pham PC, Pham PM, Pham SV et al. Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol 2007; 2: 366-373
4. Dimke H, Hoenderop JG, Bindels RJ. Hereditary tubular transport disorders: Implications for renal handling of Ca21 and Mg21. Clin Sci (Lond) 2010; 118: 1-18
5. Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidney J 2012; 5(Suppl 1): I3-i14
6. Geiger H,Wanner C. Magnesium in disease. Clin Kidney J 2012; 5(Suppl 1): I25-i38
7. Knoers NV. Inherited forms of renal hypomagnesemia: An update. Pediatr Nephrol 2009; 24: 697-705
8. Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol 2007; 18: 2649-2652
9. Kesteloot H, Joossens JV. The relationship between dietary intake and urinary excretion of sodium, potassium, calcium and magnesium: Belgian Interuniversity Research on Nutrition and Health. J Hum Hypertens 1990; 4: 527-533
10. Kopple JD, Coburn JW. Metabolic studies of low protein diets in uremia. II. Calcium, phosphorus and magnesium. Medicine (Baltimore) 1973; 52: 597-607
11. Spencer H, Lesniak M, Gatza CA et al. Magnesium absorption and metabolism in patients with chronic renal failure and in patients with normal renal function. Gastroenterology 1980; 79: 26-34
12. Alfrey AC, Miller NL, Trow R. Effect of age and magnesium depletion on bone magnesium pools in rats. J Clin Invest 1974; 54: 1074-1081
13. Graham L, Caesar J, Burgen A. Gastrointestinal absorption and excretion of Mg28 in man. Metabolism 1960; 9: 646-659
14. Kayne LH, Lee DB. Intestinal magnesium absorption. Miner Electrolyte Metab 1993; 19: 210-217
15. Aliaga IL, Miller DL, Wilson HD et al. Effects of resection on absorption and secretion of divalent cations by small intestine of rat. Am J Clin Nutr 1990; 52: 867-871
16. Amasheh S, Fromm M, Gunzel D. Claudins of intestine and nephron - a correlation of molecular tight junction structure and barrier function. Acta Physiol (Oxf) 2011; 201: 133-140
17. Hou J, Renigunta A, Gomes AS et al. Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium. Proc Natl Acad Sci USA 2009; 106: 15350-15355
18. Groenestege WM, Thebault S, van der WJ et al. Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia. J Clin Invest 2006; 117: 2260-2267
19. Romani A. Regulation of magnesium homeostasis and transport in mammalian cells. Arch Biochem Biophys 2007; 458: 90-102
20. Schmulen AC, Lerman M, Pak CY et al. Effect of 1,25-(OH)2D3 on jejunal absorption of magnesium in patients with chronic renal disease. Am J Physiol 1980; 238: G349-G352
21. Brannan PG, Vergne-Marini P, Pak CY et al. Magnesium absorption in the human small intestine. Results in normal subjects, patients with chronic renal disease, and patients with absorptive hypercalciuria. J Clin Invest 1976; 57: 1412-1418
22. Mawer EB, Taylor CM, Backhouse J et al. Failure of formation of 1,25-dihydroxycholecalciferol in chronic renal insufficiency. Lancet 1973; 1: 626-628
23. Fujita H, Sugimoto K, Inatomi S et al. Tight junction proteins claudin-2 and -12 are critical for vitamin D-dependent Ca21 absorption between enterocytes. Mol Biol Cell 2008; 19: 1912-1921
24. McCance RA, Widdowson EM, Lehmann H. The effect of protein intake on the absorption of calcium and magnesium. Biochem J 1942; 36: 686-691
25. Verbeek MJ, Van den Berg GJ, Lemmens AG et al. High protein intake raises apparent but not true magnesium absorption in rats. J Nutr 1993; 123: 1880-1887
26. Potter JD, Robertson SP, Johnson JD. Magnesium and the regulation of muscle contraction. Fed Proc 1981; 40: 2653-2656
27. Rude RK, Gruber HE. Magnesium deficiency and osteoporosis: Animal and human observations. J Nutr Biochem 2004; 15: 710-716
28. Le Grimellec C. Micropuncture study along the proximal convoluted tubule. Electrolyte reabsorption in first convolutions. Pflugers Arch 1975; 354: 133-150
29. Hou J, Renigunta A, Konrad M et al. Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex. J Clin Invest 2008; 118: 619-628
30. Hou J, Shan Q, Wang T et al. Transgenic RNAi depletion of claudin-16 and the renal handling of magnesium. J Biol Chem 2007; 282: 17114-17122
31. Greenberg A. Diuretic complications. Am J Med Sci 2000; 319: 10-24
32. Cohen N, Alon I, Almoznino-Sarafian D et al. Metabolic and clinical effects of oral magnesium supplementation in furosemide-treated patients with severe congestive heart failure. Clin Cardiol 2000; 23: 433-436
33. Glaudemans B, Knoers NV, Hoenderop JG et al. New molecular players facilitating Mg21 reabsorption in the distal convoluted tubule. Kidney Int 2010; 77: 17-22
34. Voets T, Nilius B, Hoefs S et al. TRPM6 forms the Mg21 influx channel involved in intestinal and renal Mg21 absorption. J Biol Chem 2004; 279: 19-25
35. Nijenhuis T, Vallon V, van der Kemp AWet al. Enhanced passive Ca21 reabsorption and reduced Mg21 channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest 2005; 115: 1651-1658
36. Ikari A, Okude C, Sawada H et al. TRPM6 expression and cell proliferation are up-regulated by phosphorylation of ERK1/2 in renal epithelial cells. Biochem Biophys Res Commun 2008; 369: 1129-1133
37. McNair P, Christiansen C, Transbol I. Effect of menopause and estrogen substitutional therapy on magnesium metabolism. Miner Electrolyte Metab 1984; 10: 84-87
38. Simon DB, Lu Y, Choate KA et al. Paracellin-1, a renal tight junction protein required for paracellular Mg21 resorption. Science 1999; 285: 103-106
39. Konrad M, Schaller A, Seelow D et al. Mutations in the tightjunction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet 2006; 79: 949-957
40. Hou J, Goodenough DA. Claudin-16 and claudin-19 function in the thick ascending limb. Curr Opin Nephrol Hypertens 2010; 19: 483-488
41. Jeck N, Schlingmann KP, Reinalter SC et al. Salt handling in the distal nephron: Lessons learned from inherited human disorders. Am J Physiol Regul Integr Comp Physiol 2005; 288: R782-R795
42. Hebert SC. Bartter syndrome. Curr Opin Nephrol Hypertens 2003; 12: 527-532
43. Ellison DH. Divalent cation transport by the distal nephron: Insights from Bartter's and Gitelman's syndromes. Am J Physiol Renal Physiol 2000; 279: F616-F625
44. Walder RY, Landau D, Meyer P et al. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet 2002; 31: 171-174
45. Schlingmann KP, Weber S, Peters M et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 2002; 31: 166-170
46. Chubanov V, Waldegger S, Schnitzler M et al. Disruption of TRPM6/TRPM7 complex formation by a mutation in the TRPM6 gene causes hypomagnesemia with secondary hypocalcemia. Proc Natl Acad Sci USA 2004; 101: 2894-2899
47. Schmitz C, Dorovkov MV, Zhao X et al. The channel kinases TRPM6 and TRPM7 are functionally nonredundant. J Biol Chem 2005; 280: 37763-37771
48. Li M, Jiang J, Yue L. Functional characterization of homo- and heteromeric channel kinases TRPM6 and TRPM7. J Gen Physiol 2006; 127: 525-537
49. Cao G, Thebault S, van der WJ et al. RACK1 inhibits TRPM6 activity via phosphorylation of the fused alpha-kinase domain. Curr Biol 2008; 18: 168-176
50. Woudenberg-Vrenken TE, Sukinta A, van der Kemp AW et al. Transient receptor potential melastatin 6 knockout mice are lethal whereas heterozygous deletion results in mild hypomagnesemia. Nephron Physiol 2011; 117: 11-19
51. Li M, Du J, Jiang J et al. Molecular determinants of Mg21 and Ca21 permeability and pH sensitivity in TRPM6 and TRPM7. J Biol Chem 2007; 282: 25817-25830
52. Chubanov V, Schlingmann KP,Waring J et al. Hypomagnesemia with secondary hypocalcemia due to a missense mutation in the putative pore-forming region of TRPM6. J Biol Chem 2007; 282: 7656-7667
53. Schrag D, Chung KY, Flombaum C et al. Cetuximab therapy and symptomatic hypomagnesemia. J Natl Cancer Inst 2005; 97: 1221-1224
54. Groenestege WM, Hoenderop JG, van den HL et al. The epithelial Mg21 channel transient receptor potential melastatin 6 is regulated by dietary Mg21 content and estrogens. J Am Soc Nephrol 2007; 17: 1035-1043
55. Tejpar S, Piessevaux H, Claes K et al. Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: A prospective study. Lancet Oncol 2007; 8: 387-394
56. Thebault S, Alexander RT, Tiel Groenestege WM et al. EGF increases TRPM6 activity and surface expression. J Am Soc Nephrol 2009; 20: 78-85
57. Ikari A, Sanada A, Okude C et al. Up-regulation of TRPM6 transcriptional activity by AP-1 in renal epithelial cells. J Cell Physiol 2010; 222: 481-487
58. Dimke H, van der WJ, Alexander TR et al. Effects of the EGFR inhibitor erlotinib on magnesium handling. J Am Soc Nephrol 2010; 21: 1309-1316
59. Gamba G, Saltzberg SN, Lombardi M et al. Primary structure and functional expression of a cDNA encoding the thiazidesensitive, electroneutral sodium-chloride cotransporter. Proc Natl Acad Sci USA 1993; 90: 2749-2753
60. Simon DB, Nelson-Williams C, Bia MJ et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 1996; 12: 24-30
61. Glaudemans B, van der WJ, Scola RH et al. A missense mutation in the Kv1.1 voltage-gated potassium channel-encoding gene KCNA1 is linked to human autosomal dominant hypomagnesemia. J Clin Invest 2009; 119: 936-942
62. Gomez-Hernandez JM, Lorra C, Pardo LA et al. Molecular basis for different pore properties of potassium channels from the rat brain Kv1 gene family. Pflugers Arch 1997; 434: 661-668
63. van der Wijst J, Glaudemans B, Venselaar H et al. Functional analysis of the Kv1.1 N255D mutation associated with autosomal dominant hypomagnesemia. J Biol Chem 2010; 285: 171-178
64. Smart SL, Lopantsev V, Zhang CL et al. Deletion of the K(V)1.1
65. Meij IC, Koenderink JB, van BH et al. Dominant isolated renal magnesium loss is caused by misrouting of the Na1/ K1-ATPase gamma-subunit. Nat Genet 2000; 26: 265-266
66. Ferre S, Veenstra GJ, Bouwmeester R et al. HNF-1B specifically regulates the transcription of the gamma a-subunit of the Na1/K1-ATPase. Biochem Biophys Res Commun 2011; 404: 284-290
67. Katz AI, Doucet A, Morel F. Na1/K1-ATPase activity along the rabbit, rat, and mouse nephron. Am J Physiol 1979; 237: F114-F120
68. Cairo ER, Friedrich T, Swarts HG et al. Impaired routing of wild type FXYD2 after oligomerisation with FXYD2-G41R might explain the dominant nature of renal hypomagnesemia. Biochim Biophys Acta 2008; 1778: 398-404
69. Sha Q, Pearson W, Burcea LC et al. Human FXYD2 G41R mutation responsible for renal hypomagnesemia behaves as an inward-rectifying cation channel. Am J Physiol Renal Physiol 2008; 295: F91-F99
70. Adalat S, Woolf AS, Johnstone KA et al. HNF1B mutations associate with hypomagnesemia and renal magnesium wasting. J Am Soc Nephrol 2009; 20: 1123-1131
71. Ferraro TN, Golden GT, Smith GG et al. Fine mapping of a seizure susceptibility locus on mouse Chromosome 1: Nomination of Kcnj10 as a causative gene. Mamm Genome 2004; 15: 239-251
72. Bockenhauer D, Feather S, Stanescu HC et al. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med 2009; 360: 1960-1970
73. Scholl UI, Choi M, Liu T et al. Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc Natl Acad Sci USA 2009; 106: 5842-5847
74. Ito M, Inanobe A, Horio Y et al. Immunolocalization of an inwardly rectifying K1 channel, K(AB)-2 (Kir4.1), in the basolateral membrane of renal distal tubular epithelia. FEBS Lett 1996; 388: 11-15
75. Cha SK, Huang C, Ding Y et al. Calcium-sensing receptor decreases cell surface expression of the inwardly rectifying K1 channel Kir4.1. J Biol Chem 2011; 286: 1828-1835
76. Neusch C, Rozengurt N, Jacobs RE et al. Kir4.1 potassium channel subunit is crucial for oligodendrocyte development and in vivo myelination. J Neurosci 2001; 21: 5429-5438
77. Marcus DC, Wu T, Wangemann P et al. KCNJ10 (Kir4.1) potassium channel knockout abolishes endocochlear potential. Am J Physiol Cell Physiol 2002; 282: C403-C407
78. Sala-Rabanal M, Kucheryavykh LY, Skatchkov SN et al. Molecular mechanisms of EAST/SeSAME syndrome mutations in Kir4.1 (KCNJ10). J Biol Chem 2010; 285: 36040-36048
79. Ferre S, Hoenderop JG, Bindels RJ. Insight into renal Mg21 transporters. Curr Opin Nephrol Hypertens 2011; 20: 169-176